Tobias Warger

1.5k total citations
21 papers, 1.2k citations indexed

About

Tobias Warger is a scholar working on Immunology, Hepatology and Epidemiology. According to data from OpenAlex, Tobias Warger has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Tobias Warger's work include Immunotherapy and Immune Responses (8 papers), Hepatitis C virus research (8 papers) and Immune Cell Function and Interaction (7 papers). Tobias Warger is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Hepatitis C virus research (8 papers) and Immune Cell Function and Interaction (7 papers). Tobias Warger collaborates with scholars based in Germany, United States and Switzerland. Tobias Warger's co-authors include Gerd Rechtsteiner, Markus P. Radsak, Hansjörg Schild, Hansjörg Schild, Edgar Schmitt, Valeska Heib, Tobias Bopp, Helmut Jonuleit, G Felten and R Heyne and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Tobias Warger

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tobias Warger Germany 12 722 356 245 244 134 21 1.2k
J P Lamelin France 18 375 0.5× 311 0.9× 230 0.9× 208 0.9× 128 1.0× 42 1.0k
Nilufer P. Seth United States 20 891 1.2× 200 0.6× 181 0.7× 277 1.1× 132 1.0× 24 1.3k
Sylvie Beaulieu Canada 9 801 1.1× 122 0.3× 81 0.3× 373 1.5× 223 1.7× 13 1.2k
Barbara Aufiero United States 12 336 0.5× 218 0.6× 71 0.3× 399 1.6× 187 1.4× 13 1.0k
Pallavur V. Sivakumar United States 20 2.0k 2.8× 356 1.0× 144 0.6× 333 1.4× 627 4.7× 36 2.4k
Judie Boisvert United States 10 1.5k 2.1× 315 0.9× 395 1.6× 158 0.6× 500 3.7× 10 1.9k
Isabelle Frémaux France 14 1.0k 1.4× 195 0.5× 45 0.2× 304 1.2× 163 1.2× 21 1.4k
Fabian de Labastida Rivera Australia 20 749 1.0× 218 0.6× 69 0.3× 192 0.8× 76 0.6× 39 1.3k
Haisheng Yu China 22 633 0.9× 289 0.8× 76 0.3× 440 1.8× 150 1.1× 54 1.3k
Dan E. Sturdevant United States 12 299 0.4× 280 0.8× 287 1.2× 317 1.3× 46 0.3× 18 910

Countries citing papers authored by Tobias Warger

Since Specialization
Citations

This map shows the geographic impact of Tobias Warger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Warger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Warger more than expected).

Fields of papers citing papers by Tobias Warger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Warger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Warger. The network helps show where Tobias Warger may publish in the future.

Co-authorship network of co-authors of Tobias Warger

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Warger. A scholar is included among the top collaborators of Tobias Warger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Warger. Tobias Warger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berg, Thomas, Karl‐Georg Simon, Stefan Mauss, et al.. (2017). Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study. Journal of Hepatology. 67(5). 918–924. 195 indexed citations
2.
3.
Petersen, Jörg, R Heyne, Stefan Mauss, et al.. (2015). Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany. Digestive Diseases and Sciences. 61(10). 3061–3071. 34 indexed citations
4.
5.
Petersen, J., R Heyne, JF Schlaak, et al.. (2014). O122 EFFECTIVENESS OF TENOFOVIR DF FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 3 YEAR FINAL RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY. Journal of Hepatology. 60(1). S51–S51. 3 indexed citations
6.
7.
Christensen, Søren, Stefan Zeuzem, Christoph Eisenbach, et al.. (2014). Integrated safety analysis of Sofosbuvir-based HCV treatment regimens from phase 3 studies. Zeitschrift für Gastroenterologie. 52(8). 1 indexed citations
8.
Petersen, John Asger, R Heyne, JF Schlaak, et al.. (2013). 768 EFFECTIVENESS OF TENOFOVIR FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 2 YEAR INTERIM RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY (GEMINIS). Journal of Hepatology. 58. S313–S313. 5 indexed citations
9.
Petersen, J., R Heyne, JF Schlaak, et al.. (2012). 537 TENOFOVIR DF FOR CHRONIC HEPATITIS B PATIENTS IN FIELD PRACTICE - RESULTS FROM THE GEMINIS GERMAN MULTICENTER OBSERVATIONAL STUDY. Journal of Hepatology. 56. S212–S213. 5 indexed citations
10.
Stein, Pamela, Gerd Rechtsteiner, Tobias Warger, et al.. (2010). UV Exposure Boosts Transcutaneous Immunization and Improves Tumor Immunity: Cytotoxic T-Cell Priming through the Skin. Journal of Investigative Dermatology. 131(1). 211–219. 22 indexed citations
11.
Kubach, Jan, Petra Lutter, Tobias Bopp, et al.. (2007). Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood. 110(5). 1550–1558. 161 indexed citations
12.
Warger, Tobias, Hansjörg Schild, & Gerd Rechtsteiner. (2007). Initiation of adaptive immune responses by transcutaneous immunization. Immunology Letters. 109(1). 13–20. 41 indexed citations
13.
Reifenberg, Kurt, Hans-Anton Lehr, Michael Torzewski, et al.. (2007). Interferon-γ Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic Mice. American Journal Of Pathology. 171(2). 463–472. 82 indexed citations
14.
Warger, Tobias, et al.. (2007). Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection. Clinical Reviews in Allergy & Immunology. 32(1). 57–65. 25 indexed citations
15.
Warger, Tobias, et al.. (2007). Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection. Clinical Reviews in Allergy & Immunology. 32(1). 57–65. 2 indexed citations
16.
Heib, Valeska, Marc A. Becker, Tobias Warger, et al.. (2007). Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood. 110(3). 946–953. 92 indexed citations
17.
Warger, Tobias, Gerd Rechtsteiner, Philipp Haselmayer, et al.. (2006). Interaction of TLR2 and TLR4 Ligands with the N-terminal Domain of Gp96 Amplifies Innate and Adaptive Immune Responses. Journal of Biological Chemistry. 281(32). 22545–22553. 102 indexed citations
18.
Rechtsteiner, Gerd, Tobias Warger, Matthias Hofmann, et al.. (2006). Precursor frequency can compensate for lower TCR expression in T cell competition during priming in vivo. European Journal of Immunology. 36(10). 2613–2623. 9 indexed citations
19.
Singh‐Jasuja, Harpreet, et al.. (2005). Glycoprotein 96–activated dendritic cells induce a CD8-biased T cell response. Cell Stress and Chaperones. 10(3). 221–221. 32 indexed citations
20.
Rechtsteiner, Gerd, et al.. (2005). Cutting Edge: Priming of CTL by Transcutaneous Peptide Immunization with Imiquimod. The Journal of Immunology. 174(5). 2476–2480. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J P Lamelin Breakdown of academic impact, for papers by Nilufer P. Seth Breakdown of academic impact, for papers by Sylvie Beaulieu Breakdown of academic impact, for papers by Barbara Aufiero Breakdown of academic impact, for papers by Pallavur V. Sivakumar Breakdown of academic impact, for papers by Judie Boisvert Breakdown of academic impact, for papers by Isabelle Frémaux Breakdown of academic impact, for papers by Fabian de Labastida Rivera Breakdown of academic impact, for papers by Haisheng Yu Breakdown of academic impact, for papers by Dan E. Sturdevant
Rankless by CCL
2026